AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
PM ETOCALA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”), announced today that Tom ...
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis
Detailed price information for Aim Immunotech Inc (AIM-A) from The Globe and Mail including charting and trades.
News Medical on MSN6d
Transposable elements found to be dysregulated in Alzheimer's brains, revealing potential targets for therapy
Study reveals widespread dysregulation of transposable elements (TEs) in aging human brains with Alzheimer's disease, using ...
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
Company raises $31 million through ATM, bringing cash runway into 2027. New additions to leadership in technical operations, finance and intellectual property prepare Codexis for ...
eLife5d
Heat Shock Factor Regulation of Antimicrobial Peptides Expression Suggests a Conserved Defense Mechanism Induced by Febrile Temperature in Arthropods
China-ASEAN Belt and Road Joint Laboratory on Mariculture Technology, Guangzhou, China ...
Yahoo Finance21h
Applied DNA Sciences, Inc. (APDN)
Despite a challenging quarter with revenue declines, Applied DNA Sciences Inc (APDN) is poised for future growth through strategic partnerships and new service launches. - Co-Hosts Seminar with ...
Medscape4d
Outlining Novel Cellular Adjuvant Products for Therapeutic Vaccines Against Cancer
Despite promising Phase II data, there was no difference in overall survival between the patients who received Canvaxin and the patients who received placebo in the randomized Phase III trial of ...